CellaVision AB (publ)
CLVSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6,837 | $4,016 | $5,575 | $7,384 |
| - Cash | $149 | $122 | $108 | $130 |
| + Debt | $27 | $65 | $102 | $137 |
| Enterprise Value | $6,714 | $3,959 | $5,569 | $7,390 |
| Revenue | $723 | $677 | $639 | $566 |
| % Growth | 6.8% | 5.9% | 13% | – |
| Gross Profit | $487 | $463 | $438 | $392 |
| % Margin | 67.3% | 68.4% | 68.6% | 69.4% |
| EBITDA | $220 | $207 | $191 | $194 |
| % Margin | 30.4% | 30.6% | 29.9% | 34.2% |
| Net Income | $141 | $130 | $118 | $125 |
| % Margin | 19.5% | 19.2% | 18.5% | 22.2% |
| EPS Diluted | 5.9 | 5.46 | 4.96 | 5.25 |
| % Growth | 8.1% | 10.1% | -5.5% | – |
| Operating Cash Flow | $198 | $196 | $137 | $160 |
| Capital Expenditures | -$78 | -$86 | -$69 | -$84 |
| Free Cash Flow | $121 | $110 | $68 | $75 |